Literature DB >> 21883563

Incurable, invisible and inconclusive: watchful waiting for chronic lymphocytic leukaemia and implications for doctor-patient communication.

J Evans1, S Ziebland, A R Pettitt.   

Abstract

Patients with chronic lymphocytic leukaemia (CLL) find it hard to accept a diagnosis of an incurable cancer for which no treatment is recommended and which may not cause symptoms for many years. We used qualitative interviews with 12 people with CLL managed by watchful waiting, drawn from a maximum variation sample of 39 adults with leukaemia, to explore accounts of watchful waiting and implications for clinical management. Patients with CLL recalled being given little information about the condition and wanted to know more about how it might affect them in the future. The invisibility of CLL meant that some chose not to disclose the diagnosis to others. Check-ups sometimes felt cursory, causing dissatisfaction. As symptoms increased, lifestyle adaptations became essential, well before treatment was warranted. Patients with CLL on watchful waiting experience levels of depression, anxiety and quality of life similar to those in active treatment; our qualitative approach has illuminated some of the reasons for the negative psychological impacts. We relate our findings to perceptions of the illness state, doctor-patient communication, and work pressure. We recommend that specialists could better support patients by acknowledging psychological impacts of CLL, actively listening to patients' concerns, and meeting their needs for information.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21883563     DOI: 10.1111/j.1365-2354.2011.01278.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  10 in total

1.  Primary care management of early stage chronic lymphocytic leukaemia is safe and effective.

Authors:  H M Parry; S Damery; N P Mudondo; P Hazlewood; T McSkeane; S Aung; J Murray; G Pratt; P Moss; D W Milligan
Journal:  QJM       Date:  2015-01-31

2.  Effect of Lenalidomide Maintenance in Chronic Lymphocytic Leukemia: A Meta-Analysis and Trial-Sequential Analysis.

Authors:  Tsung-Ying Yu; Hong-Jie Jhou; Po-Huang Chen; Cho-Hao Lee
Journal:  Curr Oncol       Date:  2022-06-14       Impact factor: 3.109

3.  Illness Perceptions in Chronic Lymphocytic Leukemia: Testing Leventhal's Self-regulatory Model.

Authors:  Travis D Westbrook; Eleshia J Morrison; Kami J Maddocks; Farrukh T Awan; Jeffrey A Jones; Jennifer A Woyach; Amy J Johnson; John C Byrd; Barbara L Andersen
Journal:  Ann Behav Med       Date:  2019-08-16

4.  Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studies.

Authors:  Marita C Lynagh; Tara Clinton-McHarg; Alix Hall; Rob Sanson-Fisher; William Stevenson; Campbell Tiley; Alessandra Bisquera
Journal:  Exp Hematol Oncol       Date:  2015-06-11

5.  Community as a source of health in three racial/ethnic communities in Oregon: a qualitative study.

Authors:  Carolyn A Mendez-Luck; Jeffrey W Bethel; R Turner Goins; Marc B Schure; Elizabeth McDermott
Journal:  BMC Public Health       Date:  2015-02-12       Impact factor: 3.295

Review 6.  Patient and provider experiences with active surveillance: A scoping review.

Authors:  Claire Kim; Frances C Wright; Nicole J Look Hong; Gary Groot; Lucy Helyer; Pamela Meiers; May Lynn Quan; Robin Urquhart; Rebecca Warburton; Anna R Gagliardi
Journal:  PLoS One       Date:  2018-02-05       Impact factor: 3.240

7.  Assessing Patients' Knowledge on Chronic Lymphocytic Leukemia: Validation of the ERIC CLL Knowledge Questionnaire in Greece.

Authors:  Christina Karamanidou; Aliki Xochelli; Maria Papaioannou; Theodoros Moysiadis; Lydia Scarfo; Mattias Mattsson; Niki Stavroyianni; Richard Rosenquist; Paolo Ghia; Kostas Stamatopoulos
Journal:  Hemasphere       Date:  2021-02-23

8.  Incurable but treatable: Understanding, uncertainty and impact in chronic blood cancers-A qualitative study from the UK's Haematological Malignancy Research Network.

Authors:  Debra A Howell; Dorothy McCaughan; Alexandra G Smith; Russell Patmore; Eve Roman
Journal:  PLoS One       Date:  2022-02-10       Impact factor: 3.240

Review 9.  Developing a Clinical Program Based on the Needs of Patients With Chronic Lymphocytic Leukemia: Preparing for Illness Episodes.

Authors:  Rose Bell
Journal:  J Adv Pract Oncol       Date:  2017-07-01

10.  Development of a Conceptual Model of Chronic Lymphocytic Leukemia to Better Understand the Patient Experience.

Authors:  Daniel Eek; Matthew Blowfield; Calvin Krogh; Helena Chung; Toby A Eyre
Journal:  Patient       Date:  2021-01       Impact factor: 3.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.